These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7875160)

  • 1. Endometrial carcinoma in breast cancer patients treated with tamoxifen. Two case report and review of the literature.
    Lanza A; Alba E; Re A; Tessarolo M; Leo L; Bellino R; Lauricella A; Wierdis T
    Eur J Gynaecol Oncol; 1994; 15(6):455-9. PubMed ID: 7875160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential oncogenic effect of tamoxifen on the endometrium.
    Berlière M; Galant C; Donnez J
    Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of endometrial cancer during tamoxifen therapy].
    Rasmussen KL; Nielsen KM
    Ugeskr Laeger; 1991 Sep; 153(38):2638. PubMed ID: 1949276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory endometrial adenocarcinoma in a patient on tamoxifen for breast cancer: a report of a case.
    Folk JJ; Mazur MT; Eddy GL; Musa AG
    Gynecol Oncol; 1995 Jul; 58(1):133-5. PubMed ID: 7789881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G; Dauplat J
    Rev Fr Gynecol Obstet; 1992 Jun; 87(6):345-8. PubMed ID: 1631476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and endometrial cancer.
    Segna RA; Dottino PR; Deligdisch L; Cohen CJ
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
    Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
    Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of tamoxifen therapy on the endometrium.
    Zarbo G; Caruso G; Zammitti M; Caruso S; Zarbo R
    Eur J Gynaecol Oncol; 2000; 21(1):86-8. PubMed ID: 10726629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tamoxifen, endometrial cancer risk and liquid based cytology. A paradigmatic case].
    Fambrini M; Buccoliero AM; Pieralli A; Andersson KL; Mattei A; Scarselli G; Taddei G; Marchionni M
    Minerva Ginecol; 2011 Oct; 63(5):465-70. PubMed ID: 21926955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial changes in post-menopausal breast cancer patients on tamoxifen.
    Al-Azemi M; Labib NS; Omu AE
    Int J Gynaecol Obstet; 2002 Oct; 79(1):47-9. PubMed ID: 12399095
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen-induced endometrial polyp. A case report and review of the literature.
    Nomikos IN; Elemenoglou J; Papatheophanis J
    Eur J Gynaecol Oncol; 1998; 19(5):476-8. PubMed ID: 9863916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A breast cancer patient with pelvic and gastric malignancy after adjuvant tamoxifen treatment for breast cancer.
    Dede M; Gezginç K; Ulubay M; Alanbay I; Güran S; Yenen M
    Eur J Gynaecol Oncol; 2008; 29(2):200. PubMed ID: 18459568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gynaecological complications of women treated with tamoxifen for breast cancer.
    Dew JE; Eden JA
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):198-200. PubMed ID: 7677689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.
    Neri F; Maggino T
    Eur J Gynaecol Oncol; 2009; 30(4):357-60. PubMed ID: 19761121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial lesions in patients undergoing tamoxifen therapy.
    De Muylder X; Neven P; De Somer M; Van Belle Y; Vanderick G; De Muylder E
    Int J Gynaecol Obstet; 1991 Oct; 36(2):127-30. PubMed ID: 1683314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.